T. Rowe Price Associates’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-85,900
| Closed | -$103K | – | 3027 |
|
|
2022
Q3 | $103K | Sell |
85,900
-37,550
| -30% | -$45K | ﹤0.01% | 2718 |
|
|
2022
Q2 | $222K | Sell |
123,450
-49,490
| -29% | -$89K | ﹤0.01% | 2556 |
|
|
2022
Q1 | $349K | Buy |
172,940
+13,100
| +8% | +$26.4K | ﹤0.01% | 2480 |
|
|
2021
Q4 | $433K | Buy |
159,840
+59,800
| +60% | +$162K | ﹤0.01% | 2456 |
|
|
2021
Q3 | $446K | Buy |
100,040
+22,646
| +29% | +$101K | ﹤0.01% | 2425 |
|
|
2021
Q2 | $449K | Sell |
77,394
-4,496
| -5% | -$26.1K | ﹤0.01% | 2427 |
|
|
2021
Q1 | $575K | Buy |
81,890
+8,604
| +12% | +$60.4K | ﹤0.01% | 2300 |
|
|
2020
Q4 | $352K | Buy |
73,286
+14,423
| +25% | +$69.3K | ﹤0.01% | 2370 |
|
|
2020
Q3 | $343K | Sell |
58,863
-6,404
| -10% | -$37.3K | ﹤0.01% | 2237 |
|
|
2020
Q2 | $441K | Sell |
65,267
-12,075
| -16% | -$81.6K | ﹤0.01% | 2095 |
|
|
2020
Q1 | $492K | Sell |
77,342
-8,085
| -9% | -$51.4K | ﹤0.01% | 1996 |
|
|
2019
Q4 | $891K | Buy |
85,427
+34,286
| +67% | +$358K | ﹤0.01% | 1934 |
|
|
2019
Q3 | $201K | Buy |
51,141
+21,416
| +72% | +$84.2K | ﹤0.01% | 2375 |
|
|
2019
Q2 | $442K | Buy |
29,725
+182
| +0.6% | +$2.71K | ﹤0.01% | 2151 |
|
|
2019
Q1 | $733K | Buy |
29,543
+3,200
| +12% | +$79.4K | ﹤0.01% | 1970 |
|
|
2018
Q4 | $473K | Sell |
26,343
-154,745
| -85% | -$2.78M | ﹤0.01% | 2093 |
|
|
2018
Q3 | $5.32M | Sell |
181,088
-135,744
| -43% | -$3.99M | ﹤0.01% | 1447 |
|
|
2018
Q2 | $14.4M | Sell |
316,832
-23,839
| -7% | -$1.08M | ﹤0.01% | 1282 |
|
|
2018
Q1 | $18M | Sell |
340,671
-543,306
| -61% | -$28.7M | ﹤0.01% | 1215 |
|
|
2017
Q4 | $60.1M | Sell |
883,977
-468,728
| -35% | -$31.9M | 0.01% | 794 |
|
|
2017
Q3 | $111M | Sell |
1,352,705
-680,558
| -33% | -$56.1M | 0.02% | 597 |
|
|
2017
Q2 | $190M | Buy |
2,033,263
+1,759,645
| +643% | +$165M | 0.03% | 449 |
|
|
2017
Q1 | $17.4M | Sell |
273,618
-165,788
| -38% | -$10.6M | ﹤0.01% | 1211 |
|
|
2016
Q4 | $19.5M | Sell |
439,406
-843,388
| -66% | -$37.5M | ﹤0.01% | 1152 |
|
|
2016
Q3 | $46.2M | Sell |
1,282,794
-238,000
| -16% | -$8.58M | 0.01% | 834 |
|
|
2016
Q2 | $20.9M | Sell |
1,520,794
-43,811
| -3% | -$601K | ﹤0.01% | 1086 |
|
|
2016
Q1 | $30M | Sell |
1,564,605
-18,290
| -1% | -$351K | 0.01% | 954 |
|
|
2015
Q4 | $55.4M | Sell |
1,582,895
-353,978
| -18% | -$12.4M | 0.01% | 729 |
|
|
2015
Q3 | $178M | Sell |
1,936,873
-288,764
| -13% | -$26.6M | 0.04% | 433 |
|
|
2015
Q2 | $196M | Sell |
2,225,637
-49,845
| -2% | -$4.38M | 0.04% | 453 |
|
|
2015
Q1 | $169M | Buy |
2,275,482
+62,078
| +3% | +$4.61M | 0.03% | 472 |
|
|
2014
Q4 | $124M | Buy |
2,213,404
+945,153
| +75% | +$52.9M | 0.03% | 554 |
|
|
2014
Q3 | $57.5M | Sell |
1,268,251
-34,800
| -3% | -$1.58M | 0.01% | 784 |
|
|
2014
Q2 | $54M | Buy |
1,303,051
+226,025
| +21% | +$9.36M | 0.01% | 840 |
|
|
2014
Q1 | $74.6M | Buy |
1,077,026
+165,171
| +18% | +$11.4M | 0.02% | 721 |
|
|
2013
Q4 | $55M | Buy |
911,855
+175,300
| +24% | +$10.6M | 0.01% | 805 |
|
|
2013
Q3 | $44.8M | Sell |
736,555
-148,888
| -17% | -$9.05M | 0.01% | 855 |
|
|
2013
Q2 | $59.3M | Buy |
+885,443
| New | +$59.3M | 0.02% | 730 |
|